Human ovarian cancer SKOV3 cells, which over express HER2, werecultured continuously for 8 months in the presence of 10 μg/ml trastuzumab, resulting in the acquisition of trastuzumab resistance in the surviving cell population. Here, ERBB2 is linked to ovarian cancer.